IDEXX Laboratories (IDXX) Short Interest Ratio & Short Volume → Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad) Free IDXX Stock Alerts $505.40 -11.10 (-2.15%) (As of 05/28/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends IDEXX Laboratories Short Interest DataCurrent Short Interest1,690,000 sharesPrevious Short Interest1,690,000 sharesChange Vs. Previous MonthNo ChangeDollar Volume Sold Short$927.02 millionShort Interest Ratio3.8 Days to CoverLast Record DateMay 15, 2024Outstanding Shares82,590,000 sharesFloat Size81,690,000 sharesShort Percent of Float2.07%Today's Trading Volume499,234 sharesAverage Trading Volume452,464 sharesToday's Volume Vs. Average110% Short Selling IDEXX Laboratories ? Sign up to receive the latest short interest report for IDEXX Laboratories and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartIDXX Short Interest Over TimeIDXX Days to Cover Over TimeIDXX Percentage of Float Shorted Over Time Ad Colonial MetalsWARNING about the death of the U.S. dollar…Where do you turn during times of economic uncertainty? Many elites trust storing their wealth in gold (which has historically boomed when the dollar’s value has plummeted!)Get Colonial Metals' new Precious Metals Investment Guide. IDEXX Laboratories Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 5/15/20241,690,000 shares $927.02 million No Change2.1%3.8 $548.53 4/30/20241,690,000 shares $832.76 million -1.2%2.1%3.9 $492.76 4/15/20241,710,000 shares $840.11 million -2.8%2.1%4.1 $491.29 3/31/20241,760,000 shares $950.28 million -2.2%2.1%4.2 $539.93 3/15/20241,800,000 shares $953.59 million +6.5%2.2%4.3 $529.77 2/29/20241,690,000 shares $972.14 million -8.2%2.1%3.7 $575.23 Get the Latest News and Ratings for IDXX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for IDEXX Laboratories and its competitors with MarketBeat's FREE daily newsletter. 2/15/20241,840,000 shares $1.05 billion -0.5%2.2%3.9 $568.83 1/31/20241,850,000 shares $952.90 million +6.3%2.3%3.8 $515.08 1/15/20241,740,000 shares $931.40 million -5.4%2.1%3.4 $535.29 12/31/20231,840,000 shares $1.02 billion -15.6%2.2%3.5 $555.05 12/15/20232,180,000 shares $1.18 billion -18.1%2.7%4.2 $541.07 11/30/20232,660,000 shares $1.24 billion -4.0%3.2%5.2 $465.82 11/15/20232,770,000 shares $1.28 billion +0.7%3.4%5.7 $460.56 10/31/20232,750,000 shares $1.10 billion No Change3.4%5.8 $399.47 10/15/20232,750,000 shares $1.17 billion +3.8%3.4%6.3 $426.18 9/30/20232,650,000 shares $1.16 billion +7.7%3.2%5.9 $437.27 9/15/20232,460,000 shares $1.11 billion -0.8%3.0%5.4 $450.69 8/31/20232,480,000 shares $1.27 billion +8.3%3.0%5.5 $511.41 8/15/20232,290,000 shares $1.17 billion -12.9%2.8%5 $509.37 7/31/20232,630,000 shares $1.46 billion +6.5%3.2%5.8 $554.73 7/15/20232,470,000 shares $1.33 billion +8.3%3.0%5.6 $536.89 6/30/20232,280,000 shares $1.15 billion +6.1%2.8%5.6 $502.23 6/15/20232,150,000 shares $1.04 billion +3.4%2.6%5.4 $481.42 5/31/20232,080,000 shares $966.72 million -5.9%2.5%5.2 $464.77 5/15/20232,210,000 shares $1.08 billion No Change2.7%5.8 $489.88 10/31/20222,390,000 shares $859.64 million +0.8%2.9%4.5 $359.68 10/15/20222,370,000 shares $769.40 million +14.5%2.9%4.5 $324.64 9/30/20222,070,000 shares $674.41 million -2.8%2.5%3.8 $325.80 9/15/20222,130,000 shares $745.16 million +10.4%2.6%3.8 $349.84 8/31/20221,930,000 shares $670.91 million -1.5%2.3%3.4 $347.62 8/15/20221,960,000 shares $766.07 million +18.1%2.4%3.3 $390.85 7/31/20221,660,000 shares $662.64 million -12.2%2.0%2.5 $399.18 7/15/20221,890,000 shares $699.56 million -4.6%2.3%2.6 $370.14 6/30/20221,980,000 shares $694.45 million +1.5%2.4%2.8 $350.73 6/15/20221,950,000 shares $651.18 million +7.7%2.3%2.8 $333.94 5/31/20221,810,000 shares $708.83 million +28.4%2.2%2.8 $391.62 5/15/20221,410,000 shares $510.67 million +13.7%1.7%2.2 $362.18 4/30/20221,240,000 shares $533.80 million +17.0%1.5%2.2 $430.48 4/15/20221,060,000 shares $526.59 million +3.9%1.3%2 $496.78 3/31/20221,020,000 shares $558.00 million +20.7%N/A1.9 $547.06Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… 3/15/2022845,000 shares $424.98 million +7.4%1.0%1.7 $502.93 2/28/2022786,800 shares $418.85 million +1.8%0.9%1.6 $532.35 2/15/2022773,000 shares $394.90 million -8.1%0.9%1.6 $510.87 1/31/2022841,000 shares $426.64 million +16.1%1.0%1.9 $507.30 1/15/2022724,700 shares $383.62 million -16.0%N/A0 $529.35 12/31/2021862,400 shares $567.86 million -2.7%1.0%2.4 $658.46 12/15/2021886,000 shares $541.84 million +40.8%1.1%2.5 $611.56 11/30/2021629,400 shares $382.72 million -10.0%0.8%1.6 $608.07 11/15/2021699,600 shares $433.02 million -3.2%0.8%1.8 $618.96 10/29/2021722,700 shares $481.42 million -1.7%0.9%1.9 $666.14 10/15/2021735,400 shares $467.09 million -7.4%0.9%1.9 $635.15 9/30/2021793,900 shares $493.73 million -37.0%0.9%2 $621.90 9/15/20211,260,000 shares $833.68 million +20.0%1.5%3.2 $661.65 8/31/20211,050,000 shares $707.45 million +23.2%1.3%2.9 $673.76 8/13/2021852,500 shares $572.97 million +1.1%1.0%2.4 $672.10 7/30/2021843,000 shares $572.00 million -4.0%1.0%2.4 $678.53 7/15/2021878,200 shares $577.35 million +5.1%1.0%2.5 $657.42 6/30/2021835,300 shares $527.53 million -2.0%1.0%2.4 $631.55 6/15/2021852,200 shares $504.72 million -0.9%1.0%2.4 $592.26 5/28/2021860,000 shares $479.97 million +22.6%1.0%2.3 $558.11 5/14/2021701,300 shares $363.32 million -5.3%0.8%1.7 $518.07 4/30/2021740,200 shares $409.06 million +0.2%0.9%1.6 $552.63 4/15/2021738,700 shares $379.81 million -10.4%N/A0 $514.16 3/31/2021824,500 shares $392.42 million -3.5%1.0%1.8 $475.95 3/15/2021854,300 shares $425.23 million +4.1%1.0%1.9 $497.75 2/26/2021820,700 shares $425.35 million +4.1%1.0%1.8 $518.28 2/12/2021788,700 shares $416.80 million -1.7%0.9%1.9 $528.47 1/29/2021802,500 shares $387.02 million +14.7%1.0%1.9 $482.27 1/15/2021699,800 shares $342.13 million -9.5%0.8%1.7 $488.90 12/31/2020773,200 shares $384.25 million +13.0%0.9%1.9 $496.96 12/15/2020684,500 shares $313.62 million -16.8%0.8%1.7 $458.17 11/30/2020823,100 shares $373.88 million -20.1%1.0%2 $454.23 11/15/20201,030,000 shares $467.25 million +12.1%1.2%2.4 $453.64 10/30/2020919,200 shares $406.10 million -19.4%1.1%2.2 $441.80 10/15/20201,140,000 shares $479.38 million -8.8%1.4%2.7 $420.51 9/30/20201,250,000 shares $491.39 million +2.5%1.5%2.9 $393.11 9/15/20201,220,000 shares $450.47 million No Change1.5%2.7 $369.24 8/31/20201,220,000 shares $477.09 million +0.8%1.5%2.7 $391.06 8/14/20201,210,000 shares $459.07 million -11.7%1.4%2.4 $379.40 7/31/20201,370,000 shares $544.92 million -13.8%1.6%2.7 $397.75 7/15/20201,590,000 shares $538.17 million -17.6%1.9%3.1 $338.47 6/30/20201,930,000 shares $637.21 million +2.7%2.3%3.6 $330.16 6/15/20201,880,000 shares $581.33 million -8.3%2.2%3.1 $309.22 5/29/20202,050,000 shares $627.57 million -3.8%2.5%2.8 $306.13 5/15/20202,130,000 shares $627.03 million +3.4%2.5%2.9 $294.38 4/30/20202,060,000 shares $570.97 million -0.5%2.5%2.8 $277.17 4/15/20202,070,000 shares $533.69 million +37.1%2.5%2.9 $257.82 3/31/20201,510,000 shares $410.42 million -12.2%1.8%2.1 $271.80 3/13/20201,720,100 shares $444.78 million +35.4%2.0%2.6 $258.58 2/28/20201,270,000 shares $232.33 million -4.5%1.5%2.5 $182.94Must-See: Elon’s New Invention is Absolutely Insane (Ad)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.Click here for the full story… 2/14/20201,330,000 shares $339.63 million +0.8%1.6%2.7 $255.36 1/31/20201,320,000 shares $342.47 million +9.1%1.6%2.7 $259.45 1/15/20201,210,000 shares $342.89 million -6.9%1.4%2.4 $283.38 12/31/20191,300,000 shares $365.00 million -0.8%1.5%2.7 $280.77 8/15/20191,217,200 shares $337.32 million +1.1%1.4%3.1 $277.13 IDXX Short Interest - Frequently Asked Questions What is IDEXX Laboratories' current short interest? Short interest is the volume of IDEXX Laboratories shares that have been sold short but have not yet been covered or closed out. As of May 15th, investors have sold 1,690,000 shares of IDXX short. 2.07% of IDEXX Laboratories' shares are currently sold short. Learn More on IDEXX Laboratories' current short interest. What is a good short interest ratio for IDEXX Laboratories? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. IDXX shares currently have a short interest ratio of 4.0. Learn More on IDEXX Laboratories's short interest ratio. Which institutional investors are shorting IDEXX Laboratories? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of IDEXX Laboratories: Walleye Trading LLC, Jane Street Group LLC, PEAK6 Investments LLC, Capstone Investment Advisors LLC, BNP Paribas Financial Markets, Concourse Financial Group Securities Inc., SpiderRock Advisors LLC, and Caas Capital Management LP. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for IDEXX Laboratories? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.07% of IDEXX Laboratories' floating shares are currently sold short. What is IDEXX Laboratories' float size? IDEXX Laboratories currently has issued a total of 82,590,000 shares. Some of IDEXX Laboratories' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. IDEXX Laboratories currently has a public float of 81,690,000 shares. How does IDEXX Laboratories' short interest compare to its competitors? 2.07% of IDEXX Laboratories' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to IDEXX Laboratories: Humana Inc. (3.03%), Alcon Inc. (0.82%), Centene Co. (1.80%), IQVIA Holdings Inc. (1.68%), Takeda Pharmaceutical Company Limited (0.21%), Cencora, Inc. (4.95%), Haleon plc (0.42%), GE HealthCare Technologies Inc. (2.44%), DexCom, Inc. (1.96%), Biogen Inc. (2.41%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.81 billion), Charter Communications, Inc. ($3.30 billion), Occidental Petroleum Co. ($3.10 billion), General Motors ($2.84 billion), Moderna, Inc. ($2.77 billion), AppLovin Co. ($2.22 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.16 billion), Tractor Supply ($2.12 billion), and Williams-Sonoma, Inc. ($2.12 billion). View all of the most shorted stocks. What does it mean to sell short IDEXX Laboratories stock? Short selling IDXX is an investing strategy that aims to generate trading profit from IDEXX Laboratories as its price is falling. IDXX shares are trading down $11.10 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against IDEXX Laboratories? A short squeeze for IDEXX Laboratories occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of IDXX, which in turn drives the price of the stock up even further. How often is IDEXX Laboratories' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including IDXX, twice per month. The most recent reporting period available is May, 15 2024. More Short Interest Resources from MarketBeat Related Companies: Humana Short Interest Alcon Short Interest Centene Short Interest IQVIA Short Interest Takeda Pharmaceutical Short Interest Cencora Short Interest Haleon Short Interest GE HealthCare Technologies Short Interest DexCom Short Interest Biogen Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:IDXX) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding IDEXX Laboratories, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.